HEPA - Hepion Pharmaceuticals, Inc.
IEX Last Trade
0.471
-0.020 -4.246%
Share volume: 0
Last Updated: Fri 27 Dec 2024 06:19:16 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.90%
PREVIOUS CLOSE
CHG
CHG%
$0.49
-0.02
-4.07%
Summary score
10%
Profitability
0%
Dept financing
10%
Liquidity
50%
Performance
10%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-30.25%
Return on assets
-26.71%
Return on sales
0%
Return on invested capital
-17.95%
Total debt ratio
60.26%
Debt ratio change over timeo
-1.39%
Current Ratio
4.01%
Quick Ratio
0%
Cash Position Ratio
4.4%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-19.14%
Return on assets
-14.45%
Return on sales
0%
Return on invested capital
-95.44%
Total debt ratio
23.52%
Debt ratio change over timeo
-1.36%
Current Ratio
8.53%
Quick Ratio
0%
Cash Position Ratio
8.31%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-27.01%
Return on assets
-19.83%
Return on sales
0%
Return on invested capital
-149.18%
Total debt ratio
24.05%
Debt ratio change over time
-1.58%
Current Ratio
6.98%
Quick Ratio
0%
Cash Position Ratio
6.75%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-109.57%
Return on assets
-82.74%
Return on sales
0%
Return on invested capital
169.02%
Total debt ratio
-138.84%
Debt ratio change over time
-1.39%
Current Ratio
-5.58%
Quick Ratio
0%
Cash Position Ratio
-6.03%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | HEPA | LLY | NVO | JNJ |
|---|---|---|---|---|
| Return on equity | -30.25% | 17.45% | 19.89% | 4.69% |
| Return on assets | -26.71% | 3.37% | 11.41% | 3.35% |
| Return on sales | 0% | 23.96% | 42.05% | 25.96% |
| Return on invested capital | -17.95% | 5.2% | -272.99% | 4.37% |
| Profitability | 0% | 69% | 75% | 50% |
| Total debt ratio | 60.26% | 77% | 53.92% | 57.66% |
| Debt ratio change over time | -1.39% | 0.36% | -1.16% | 10.77% |
| Dept financing | 20% | 26% | 18% | 44% |
| Current Ratio | 8.53% | 1.16% | 1.05% | 1.27% |
| Quick Ratio | 0% | 0.89% | 0.77% | 1.01% |
| Cash Position Ratio | 8.31% | 0.17% | 0.31% | 0.53% |
| Liquididy | 50% | 30% | 25% | 39% |
| Short-term ratios | HEPA | LLY | NVO | JNJ |
|---|---|---|---|---|
| Return on equity | -19.14% | 44.06% | 17.3% | 6.24% |
| Return on assets | -14.45% | 3.88% | 9.33% | 3.22% |
| Return on sales | 0% | 27.04% | 40.02% | 24.93% |
| Return on invested capital | -95.44% | 9.69% | -224.06% | 4.96% |
| Profitability | 0% | 77% | 60% | 41% |
| Total debt ratio | 23.52% | 91.8% | 55.88% | 61.39% |
| Debt ratio change over time | -1.36% | 8.35% | -0.88% | 10.36% |
| Dept financing | 6% | 45% | 15% | 42% |
| Current Ratio | 8.53% | 1.16% | 1.05% | 1.27% |
| Quick Ratio | 0% | 0.89% | 0.77% | 1.01% |
| Cash Position Ratio | 8.31% | 0.17% | 0.31% | 0.53% |
| Liquididy | 50% | 26% | 23% | 30% |